Patents by Inventor Gerassimos Makrigiorgos

Gerassimos Makrigiorgos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240052342
    Abstract: The disclosure provides a powerful new approach to dual-strand high-throughput next-generation sequencing that improves upon duplex sequencing. The method provides a novel multi-oligonucleotide adapter construct that is ligated to DNA fragments to be sequenced (e.g., genomic DNA fragments) library construction method that concatenates both strands of each DNA duplex into a linear sequence. By physically linking both strands, the products are self-sufficient to form duplex consensus. This strategy has the potential to provide 1,000-fold more accurate sequencing with minimal added cost, and could directly enhance existing products (WGS, WES, targeted panels) offered at the Genomics Platform.
    Type: Application
    Filed: December 10, 2021
    Publication date: February 15, 2024
    Applicants: The Broad Institute, Inc, Dana-Farber Cancer Institute, Inc.
    Inventors: Viktor A. Adalsteinsson, Jin Bae, Ruolin Liu, Gerassimos Makrigiorgos
  • Patent number: 11884970
    Abstract: Disclosed herein are methods to improve the efficiency of absolute quantification of nucleic acid targets such as digital PCR and digital isothermal amplification, and/or reduce the amount of nucleic acid sample required to determine the absolute quantity of target sequences in the sample.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: January 30, 2024
    Assignee: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Gerassimos Makrigiorgos, Cloud P. Paweletz
  • Publication number: 20230392191
    Abstract: The present disclosure provides methods for preparing a target mutant nucleic acid for subsequent enrichment relative to a wild-type nucleic acid using nucleases that have a substantially higher activity on double stranded DNA versus single stranded DNA or RNA. The present disclosure also includes methods for enriching a target mutant nucleic acid and for preparing unmethylated/methylated nucleic acids of interest for subsequent enrichment.
    Type: Application
    Filed: August 13, 2023
    Publication date: December 7, 2023
    Inventors: Gerassimos MAKRIGIORGOS, Chen SONG
  • Publication number: 20230357854
    Abstract: Presently described are methods for enriching regions of a genome in a sample using ligation of fragmented genomic nucleic acid and amplification using repeat elements. The methods can be used for a number of applications, including genome-wide homopolymer indel detection, and enable increasing the amount of information obtained from a limited sample of genomic nucleic acid.
    Type: Application
    Filed: August 23, 2021
    Publication date: November 9, 2023
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventor: Gerassimos Makrigiorgos
  • Patent number: 11725230
    Abstract: The present disclosure provides methods for preparing a target mutant nucleic acid for subsequent enrichment relative to a wild type nucleic acid using nucleases that have a substantially higher activity on double stranded DNA versus single stranded DNA or RNA. The present disclosure also includes methods for enriching a target mutant nucleic acid and for preparing unmethylated/methylated nucleic acids of interest for subsequent enrichment.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: August 15, 2023
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Gerassimos Makrigiorgos, Chen Song
  • Publication number: 20230203568
    Abstract: The disclosure provides novel methods, compositions, and kits that combine hybrid capture using short allele-specific probes with duplex molecular” barcoding and noise modeling within each sample to afford high accuracy sequencing of rare mutations at low cost.
    Type: Application
    Filed: January 14, 2021
    Publication date: June 29, 2023
    Applicants: The Broad Institute, Inc., Dana-Farber Cancer Institute, Inc.
    Inventors: Viktor A. Adalsteinsson, Gregory Gydush, Gerassimos Makrigiorgos, Erica Nguyen
  • Publication number: 20220290209
    Abstract: Presently described are compositions and methods for performing genome-wide enrichment of DNA microsatellites (e.g., homopolymers) containing deletions and facilitating their detection via sequencing or other downstream methodologies. Additionally, disclosed herein are compositions and methods for selecting the genomic fraction containing poly-adenine/poly-thymidine homopolymer repeats and other A:T-rich sequences of low melting temperature from the genome, so that very little sequencing is required to detect the enriched homo-polymer deletions.
    Type: Application
    Filed: August 20, 2020
    Publication date: September 15, 2022
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventor: Gerassimos Makrigiorgos
  • Patent number: 11371090
    Abstract: Provided herein are methods to determine the original abundance of mutant alleles of one or more barcoded target sequences following mutation enrichment and sequencing.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: June 28, 2022
    Assignees: Dana-Farber Cancer Institute, Inc., The Broad Institute, Inc.
    Inventors: Gerassimos Makrigiorgos, Viktor A. Adalsteinsson
  • Patent number: 11174510
    Abstract: The present invention is directed to methods, compositions and software for enriching low abundance alleles in a sample. It is directed in particular to the use of an excess amount of reference blocking sequence in an amplification reaction mixture in order to improve the enrichment efficiency, and reduce cycle time, of full COLD-PCR.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: November 16, 2021
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventor: Gerassimos Makrigiorgos
  • Patent number: 11174511
    Abstract: This disclosure relates to compositions and methods for single-step, multi-stage amplification reactions that combine many stages of sample preparation process in a single tube reaction. The disclosed technology provides a mean of performing multiplexed nested PCR in a single vessel, without any need of purification steps, and is based on the use of three sets of primers: a pair of outer primers, a pair of inner primers that are nested within the pair of outer primers, and tail primers that are complementary to tails on the inner primers. By adjusting the temperature conditions, annealing temperatures of the primers, number of amplification cycles, and the concentrations of the outer, inner, and tail primers, it is possible to carry out multiplexed nested PCR in a single vessel.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: November 16, 2021
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventor: Gerassimos Makrigiorgos
  • Publication number: 20210310061
    Abstract: Disclosed herein are compositions and methods for isothermal amplification of dsDNA without the use of primers. The dis-closed compositions and methods may be used for the generation of probes used in hybrid-capture techniques that usually precede sequencing. Methods of using the probes for capturing target DNA are also provided.
    Type: Application
    Filed: August 16, 2019
    Publication date: October 7, 2021
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Gerassimos Makrigiorgos, Ka Wai Leong, Fangyan Yu
  • Patent number: 11130992
    Abstract: The present invention is directed to methods, compositions and reaction mixtures for multiplexing COLD-PCR/ice-COLD-PCR to enrich simultaneously several low abundance alleles (mutant target sequences) from a sample. The invention also involves COLD-PCR/ice-COLD-PCR amplification performed on DNA fragments that have different melting temperatures, and therefore different critical denaturation temperatures, in a graded temperature approach such that mutation enrichment is achieved on all diverse DNA fragments simultaneously (temperature-independent COLD-PCR or TI-COLD-PCR). The invention also involves methods for enabling identification of variant-sequence alleles in the presence of a large excess of non-variant alleles in nucleic acids without the complication of polymerase-introduced errors or other primer-introduced artifacts.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: September 28, 2021
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventor: Gerassimos Makrigiorgos
  • Publication number: 20210214778
    Abstract: Disclosed herein are methods to improve the efficiency of absolute quantification of nucleic acid targets such as digital PCR and digital isothermal amplification, and/or reduce the amount of nucleic acid sample required to determine the absolute quantity of target sequences in the sample.
    Type: Application
    Filed: May 24, 2019
    Publication date: July 15, 2021
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Gerassimos Makrigiorgos, Cloud P. Paweletz
  • Patent number: 10913977
    Abstract: The present invention is directed to methods, compositions and reaction mixtures for conducting COLD-PCR, by controlling and varying a preferential denaturation time.
    Type: Grant
    Filed: July 21, 2014
    Date of Patent: February 9, 2021
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventor: Gerassimos Makrigiorgos
  • Publication number: 20200370108
    Abstract: This disclosure relates to compositions and methods for single-step, multi-stage amplification reactions that combine many stages of sample preparation process in a single tube reaction. The disclosed technology provides a mean of performing multiplexed nested PCR in a single vessel, without any need of purification steps, and is based on the use of three sets of primers: a pair of outer primers, a pair of inner primers that are nested within the pair of outer primers, and tail primers that are complementary to tails on the inner primers. By adjusting the temperature conditions, annealing temperatures of the primers, number of amplification cycles, and the concentrations of the outer, inner, and tail primers, it is possible to carry out multiplexed nested PCR in a single vessel.
    Type: Application
    Filed: July 24, 2018
    Publication date: November 26, 2020
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventor: Gerassimos MAKRIGIORGOS
  • Patent number: 10835604
    Abstract: Compositions and methods for the radiological and immunotherapeutic treatment of cancer are provided. Metallic nanoparticles conjugated with an immunoadjuvant are dispersed within a biodegradable polymer matrix that can be implanted in a patient and released gradually. The implant may be configured as, or be a component of, brachytherapy spacers and applicators, or radiotherapy fiducial markers. The composition may be combined with marginless radiotherapy, allowing for lower doses of radiation and enhancing the immune response against cancer, including at non-irradiated sites.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: November 17, 2020
    Assignees: Northeastern University, Dana-Farber Cancer Institute, Inc., The Brigham and Women's Hospital, Inc.
    Inventors: Wilfred Ngwa, Rajiv Kumar, Gerassimos Makrigiorgos, Srinivas Sridhar, Stephanie Dougan
  • Patent number: 10799604
    Abstract: A method of detecting migration of tumor cells is provided by implanting in a region of tumor cells one or more implants having a matrix material of a biocompatible and biodegradable polymer, and a plurality of nanoparticles dispersed within the matrix material and functionalized to bind tumor cells. Nanoparticles bound to the tumor cells that have migrated out of the region can be detected by various imaging modalities. The implant can be in the shape of a brachytherapy spacer or radiotherapy fiducial maker or can be a coating on a brachytherapy spacer or fiducial marker. A method of treating cancer is provided by implanting one or more brachytherapy spacers or fiducial markers including the matrix material and an anti-cancer therapeutic agent dispersed within the matrix material.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: October 13, 2020
    Assignees: Northeastern University, Dana-Farber Cancer Institute, Inc., The Brigham and Women's Hospital, Inc.
    Inventors: Rajiv Kumar, Srinivas Sridhar, Wilfred Ngwa, Robert Cormack, Gerassimos Makrigiorgos
  • Publication number: 20200040388
    Abstract: Provided herein are methods to determine the original abundance of mutant alleles of one or more barcoded target sequences following mutation enrichment and sequencing.
    Type: Application
    Filed: December 12, 2017
    Publication date: February 6, 2020
    Applicants: Dana-Farber Cancer Institute, Inc., The Broad Institute, Inc.
    Inventors: Gerassimos Makrigiorgos, Viktor A. Adalsteinsson
  • Publication number: 20180282798
    Abstract: The present invention is directed to methods, compositions and software for enriching low abundance alleles in a sample. It is directed in particular to the use of an excess amount of reference blocking sequence in an amplification reaction mixture in order to improve the enrichment efficiency, and reduce cycle time, of full COLD-PCR.
    Type: Application
    Filed: March 29, 2018
    Publication date: October 4, 2018
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventor: Gerassimos Makrigiorgos
  • Publication number: 20180271978
    Abstract: Compositions and methods for the radiological and immunotherapeutic treatment of cancer are provided. Metallic nanoparticles conjugated with an immunoadjuvant are dispersed within a biodegradable polymer matrix that can be implanted in a patient and released gradually. The implant may be configured as, or be a component of, brachytherapy spacers and applicators, or radiotherapy fiducial markers. The composition may be combined with marginless radiotherapy, allowing for lower doses of radiation and enhancing the immune response against cancer, including at non-irradiated sites.
    Type: Application
    Filed: August 15, 2016
    Publication date: September 27, 2018
    Applicants: Northeastern University, Dana-Farber Cancer Institute, Inc., The Brigham and Women's Hospital, Inc.
    Inventors: Wilfred Ngwa, Rajiv Kumar, Gerassimos Makrigiorgos, Srinivas Sridhar, Stephanie Dougan